STOCK TITAN

MedAvail Holdings Inc - MDVL STOCK NEWS

Welcome to our dedicated news page for MedAvail Holdings (Ticker: MDVL), a resource for investors and traders seeking the latest updates and insights on MedAvail Holdings.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect MedAvail Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of MedAvail Holdings's position in the market.

Rhea-AI Summary
MedAvail Holdings, Inc. (MDVL) expands its presence among Federally Qualified Health Centers (FQHCs) by entering into an agreement with St. Thomas Community Health Centers for the deployment of two M4 MedCenter kiosks. This partnership aims to provide affordable health care to underserved communities across the New Orleans metropolitan area, utilizing 340B savings to improve medication access and adherence, and improve health outcomes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.99%
Tags
none
-
Rhea-AI Summary
MedAvail Holdings, Inc. (Nasdaq: MDVL) received a delinquency notification letter from Nasdaq, indicating non-compliance with filing its Quarterly Report on Form 10-Q. The company has 60 days to submit a plan to regain compliance, with a potential extension until May 13, 2024. The delinquency has no immediate effect on the stock listing.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
MedAvail Holdings, Inc. (Nasdaq: MDVL) has entered an agreement with Pharmacy Fund 1 to deploy ten M4 MedCenter kiosks at ASP Cares Pharmacy in Las Vegas. The first three deployments are planned for early 2024. This represents an expansion of MedAvail's successful relationship with Oak Lawn Pharmacy in Dallas. The agreement aims to improve patient access to medications and is expected to result in efficient and timely deployments.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
17.45%
Tags
none
Rhea-AI Summary
MedAvail CEO to participate in H.C. Wainwright conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.24%
Tags
conferences
-
Rhea-AI Summary
MedAvail Holdings, Inc. reports Q2 2023 financial results, with net revenue of $405,000 and the placement of two new MedCenters. The company expects to place a total of 25 net new revenue generating MedCenters in 2023. MedAvail's pipeline is growing in primary care and urgent care channels, and they have expanded into Federally Qualified Health Centers. The integration with Texas Health Resources has had a positive impact on the pipeline. The company is well financed and expects to achieve operating cash flow breakeven in 2025 without additional equity financings.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.26%
Tags
-
Rhea-AI Summary
MedAvail Holdings, Inc. (Nasdaq: MDVL) has entered an agreement with Oak Lawn Pharmacy to deploy ten M4 MedCenter kiosks across Texas. At least two kiosks will be deployed in 2023, with the remainder within 24 months. Oak Lawn will fund the setup costs. The partnership aims to improve medication access and patient outcomes in Texas, particularly in rural areas.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3%
Tags
none
Rhea-AI Summary
MedAvail Holdings, Inc. (Nasdaq: MDVL) has announced a 1-for-50 reverse stock split of its outstanding shares of common stock to regain compliance with the Minimum Bid Price Requirement of $1.00 per share for continued listing on The Nasdaq Capital Market. The reverse stock split reduces the number of shares from approximately 81 million to approximately 1.6 million shares, with adjustments made to outstanding warrants, stock options, and other equity awards.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.14%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
17.2%
Tags
none
-
Rhea-AI Summary
MedAvail Holdings, Inc. reports Q1 2023 financial results, reaffirms full-year guidance. Pipeline continues to grow with new and existing partners. Cost savings opportunities identified. Regulatory landscape evolving in favor of remote kiosk pharmacy dispensing. Company expects total revenue of $3 million and gross margins in excess of 60% for 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.4%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.29%
Tags
conferences earnings
MedAvail Holdings Inc

Nasdaq:MDVL

MDVL Rankings

MDVL Stock Data

2.91M
380.04k
0.38%
87.06%
0.64%
All Other Miscellaneous Chemical Product and Preparation Manufacturing
Manufacturing
Link
United States
Phoenix

About MDVL

medavail inc. is the developer of the medcenter automated dispensing and medication management technologies. the company designs and manufactures pharmacist-controlled automated prescription medicine dispensing vaults, similar in appearance to atms. intended for deployment in hospitals, pharmacies, medical clinics, and other locations. the company integrates advanced robotics, two-way video teleconferencing, and a secure network for patients medical information to create a prescription medication dispensing system.